CClinicalTrials.gg
CompletedNCT03304236Updated Oct 5, 2021

Motion Analysis of the Myelopathy Hand: New Insight Into the Classical Sign

An observational study in Cervical Myelopathy, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Per ClinicalTrials.gov, last updated 2021-10-05.

Sponsored by The University of Hong Kong · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Sex
All
01

Study summary

This study aims to quantify the clumsiness and decreased dexterity seen in the grip and release test using a simple glove with sensors that can quantify the abnormal motion of this classical sign. This new tool will give a mechanistic insight into the myelopathy. The findings of this study will also form the basis of a prospective longitudinal study with clinical and radiological evaluation to compare the prognosticating value of this new information in clinical practice.

Read the detailed description

Cervical myelopathy is a common condition due to degeneration of the cervical spine causing stenosis and cord compression, with a higher prevalence in Asian population. It leads to decreased hand dexterity and function, sensory loss, gait and sphincter disturbance. Natural history shows a stepwise deterioration in most cases, whilst a slow progressive deterioration or sudden deterioration is observed in small number of subjects.

The myelopathy hand was first described by Ono et al. on the analysis of finger motion impairment caused by cervical myelopathy. They described a 10 second grip and release test, which documents the number of times a subject can make a fist and release it as rapidly as possible within 10 seconds. The clumsiness associated with intrinsic finger weakness decreases the number of cycles a patient can perform during the test. They quantified patients' neurologic deficit and found that \<20 grip -release cycles in 10 seconds represented symptomatic myelopathy. The presence of this sign is not only pathognomonic of cervical myelopathy but also correlates with disease severity. This is a sensitive and specific sign of pyramidal tract involvement and has since become a classical sign and objective test of the condition. The presence of myelopathic hand signs aids the diagnosis of symptomatic cervical myelopathy and its grading acts a guide to the severity of the condition to the treating surgeon.

However, this quantitative analysis only provides a crude representation of the clumsiness that patients experience from their deterioration of hand function. In the original description, Ono et al. noted the quality of this movement was affected particularly in advanced cases, where there was difficult, slow and incomplete finger extension, exaggerated wrist flexion with attempted finger extension and exaggerated wrist extension with finger flexion. This was considered to be caused by a failure of synergy between the wrist and the fingers. Finger motion is complex, varies greatly and clinical evaluation is often difficult. Apart from the counting the number of cycles a patient can perform, the classical grip and release test contains other critical clinical information that has been widely described by surgeons but in very vague terms that are neither reproducible nor meaningful in clinical practice. Although this uncoordinated finger motion and inability to move their fingers smoothly in grip and release cycles are well-known phenomena in myelopathy patients, they have been only vaguely recognized. Presently these kinematic characteristics have not been quantified or studied, and it is not known which types of myelopathy present with them, how it correlates with disease severity and its prognosticating value.

02

Conditions studied

  • Cervical Myelopathy

Keywords

  • Cervical Myelopathy
  • sEMG
  • Motion capture analysis
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients at the Duchess of Kent Children's Hospital will be selected.

Inclusion criteria

  • All degenerative causes of documented cervical myelopathy planned for operation will be recruited into the study.

Exclusion criteria

Exclusion Criteria:

  • Patients found to have spinal tumour, infection, or other non-degenerative causes as well as patient who are unable to follow command and/or unwilling to attend follow up will be excluded from the study.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No

Groups and cohorts

  • Myelopathy hand

    Patients will undergo radiological and clinical examination at the Duchess of Kent Children Hospital. Patients will be required to put on a pair of hand gloves with 18 IMUs located on specific bony landmarks (distal phalanges of fingers, proximal phalanges of index fingers and thumbs, dorsum of the hands and bilateral wrists).

    Device: Myelopathy Hand

Interventions

  • DeviceMyelopathy Hand

    Patients will undergo radiological and clinical examination at the Duchess of Kent Children Hospital. Patients will be required to put on a pair of hand gloves with 18 IMUs located on specific bony landmarks (distal phalanges of fingers, proximal phalanges of index fingers and thumbs, dorsum of the hands and bilateral wrists)

05

What researchers measure

Primary outcomes

  1. Objective quantification of the hand movement during grip and release test using sEMG and motion capture analysis

    Objective quantification of the hand movement during grip and release test using sEMG and motion capture analysis

    Time frame: 1 year

Secondary outcomes

  1. Correlate the clinical severity of myelopathy with different patterns of hand movement using sEMG and motion capture analysis

    To correlate the clinical severity of myelopathy with different patterns of hand movement using sEMG and motion capture analysis

    Time frame: 1 year

  2. Correlate the radiological level of myelopathy involvement with different patterns of hand movement using sEMG and motion capture analysis

    To correlate the radiological level of myelopathy involvement with different patterns of hand movement using sEMG and motion capture analysis

    Time frame: 1 year

  3. Devise a new severity score based on different patterns of hand movement using sEMG and motion capture analysis

    To devise a new severity score based on different patterns of hand movement nursing sEMG and motion capture analysis

    Time frame: 1 year

06

Study locations

1 site
  • Duchess of Kent Children's Hospital
    Hong Kong, Hong Kong
07

References and documents

Publications

  • Ono K, Okada K and Fuji T. Finger escape sign (FES), an objective sign signifying pyramidal tract involvement of the cervical spinal cord. Orthop Trans 1982; 6.2:181.
  • Ono K, Ebara S, Fuji T, Yonenobu K, Fujiwara K, Yamashita K. Myelopathy hand. New clinical signs of cervical cord damage. J Bone Joint Surg Br. 1987 Mar;69(2):215-9. doi: 10.1302/0301-620X.69B2.3818752. PubMed 3818752 ↗
  • Taylor T, Ko S, Mastrangelo C, Bamberg SJ. Forward kinematics using IMU on-body sensor network for mobile analysis of human kinematics. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:1230-3. doi: 10.1109/EMBC.2013.6609729. PubMed 24109916 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03304236
Lead sponsor
The University of Hong Kong
Collaborators
The Hong Kong Polytechnic University
Responsible party
Dr. Kenny Kwan (Clinical Assistant Professor, The University of Hong Kong) — Principal investigator
First posted
Oct 6, 2017
Start date
Jul 1, 2017
Primary completion
Mar 31, 2019
Completion
Jun 30, 2020
Last update
Oct 5, 2021

Study contacts

Dr Kenny Kwan, BMBCh(Oxon)
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion